Note 13 - Segment Information

6 Months Ended

Jun. 29, 2024

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

13.   Segment Information

The Company follows ASC 280, “Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Consolidated Financial Statements included in its Annual Report on Form 10-K for the year ended December 30, 2023).

Segment operating income includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system:

Thirteen Weeks Ended June 29, 2024	Specialty Health Care		Engineering		Life Sciences and IT		Corporate			Total
Revenue	$	36,932	$	22,508	$	9,724	$	-		$	69,164
Cost of services		26,293		16,542		6,328		-			49,163
Gross profit		10,639		5,966		3,396		-			20,001
Selling, general and administrative		7,254		4,049		2,242		-			13,545
Depreciation and amortization of property and equipment		127		162		43		-			332
Amortization of acquired intangible assets		-		-		46		-			46
Costs associated with potential stock issuance		-		-		-		259			259
Operating income (loss)	$	3,258	$	1,755	$	1,065	$	(259	)	$	5,819
Total assets as of June 29, 2024	$	40,236	$	47,387	$	20,390	$	10,265		$	118,278
Property and equipment acquired	$	60	$	45	$	6	$	287		$	398

Thirteen Weeks Ended July 1, 2023	Specialty Health Care		Engineering		Life Sciences and IT		Corporate		Total
Revenue	$	35,528	$	21,014	$	10,493	$	-	$	67,035
Cost of services		25,727		16,192		6,356		-		48,275
Gross profit		9,801		4,822		4,137		-		18,760
Selling, general and administrative		6,043		4,380		2,300		-		12,723
Depreciation and amortization of property and equipment		92		116		34		-		242
Amortization of acquired intangible assets		-		-		46		-		46
Operating income	$	3,666	$	326	$	1,757	$	-	$	5,749
Total assets as of July 1, 2023	$	39,961	$	42,668	$	17,947	$	4,961	$	105,537
Property and equipment acquired	$	29	$	190	$	2	$	7	$	228

Twenty-Six Weeks Ended June 29, 2024	Specialty Health Care		Engineering		Life Sciences and IT		Corporate			Total
Revenue	$	75,114	$	46,013	$	19,976	$	-		$	141,103
Cost of services		53,409		34,540		12,786		-			100,735
Gross profit		21,705		11,473		7,190		-			40,368
Selling, general and administrative		14,718		8,242		4,784		-			27,744
Depreciation and amortization of property and equipment		231		307		81		-			619
Amortization of acquired intangible assets		-		-		91		-			91
Costs associated with potential stock issuance		-		-		-		259			259
Operating income (loss)	$	6,756	$	2,924	$	2,234	$	(259	)	$	11,655
Total assets as of June 29, 2024	$	40,236	$	47,387	$	20,390	$	10,265		$	118,278
Property and equipment acquired	$	167	$	244	$	20	$	636		$	1,067

Twenty-Six Weeks Ended July 1, 2023	Specialty Health Care		Engineering			Life Sciences and IT		Corporate		Total
Revenue	$	74,658	$	39,504		$	19,997	$	-	$	134,159
Cost of services		53,185		30,365			12,555		-		96,375
Gross profit		21,473		8,869			7,442		-		37,784
Selling, general and administrative		13,241		8,298			4,580		-		26,119
Depreciation and amortization of property and equipment		199		244			70		-		513
Amortization of acquired intangible assets		-		-			91		-		91
Gain on sale of assets		-		(395	)		-		-		(395	)
Operating income	$	8,033	$	722		$	2,701	$	-	$	11,456
Total assets as of July 1, 2023	$	39,961	$	42,668		$	17,947	$	4,961	$	105,537
Property and equipment acquired	$	47	$	478		$	19	$	15	$	559

The Company derives a majority of its revenue from offices in the United States. Revenues reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Europe. Revenue by geographic area for the thirteen and twenty-six weeks ended June 29, 2024 and July 1, 2023 was as follows:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	June 29, 2024		July 1, 2023		June 29, 2024		July 1, 2023
Revenue
United States	$	63,569	$	62,797	$	130,420	$	126,120
Canada		1,618		1,832		3,087		3,413
Puerto Rico		2,019		1,540		4,020		3,102
Europe		1,958		866		3,576		1,524
	$	69,164	$	67,035	$	141,103	$	134,159

Total assets by geographic area as of the reported periods were as follows:

	June 29, 2024		December 30, 2023
Total assets
United States	$	110,102	$	110,781
Canada		1,763		1,880
Puerto Rico		2,453		3,476
Europe		3,960		4,347
	$	118,278	$	120,484